Medical Microbiology Testing Technologies Market – Global Industry Analysis, Growth, Trends, and Forecast 2017–2024

Medical Microbiology Testing Technologies industry analysis of the medical microbiology testing technologies market on the global and regional levels. It provides historical data of 2015 along with forecast from 2016 to 2024 in terms of revenue (US$ Mn). The report also includes macroeconomic indicators along with an outlook on medical microbiology testing technologies globally. It includes drivers and restraints of the medical microbiology testing technologies market and their impact on each region during the forecast period. The report also comprises the study of current issue and opportunities for medical microbiology testing manufacturers.

Medical Microbiology Testing Technologies Market

In order to provide users of this report with comprehensive view of the market, we have included detailed competitiveness analysis and company players. The dashboard provides detailed comparison of medical microbiology testing manufacturers on parameters such as operating margin, unique selling propositions, collective market share, and geographic concentration. The study encompasses market attractiveness analysis, by indication, type, technology type, application type, end user type and region.

Global Medical Microbiology Testing Technologies Market: Segmentation

The report includes usage of Medical Microbiology Testing Technologies and the revenue generated from sales of medical microbiology testing technologies in all regions and important countries in these regions. By indication, the global medical microbiology testing technologies market has been segmented into respiratory diseases, neurological diseases, infectious diseases and others. By technology, the market is segmented into Cell Culture, Microscopy and Serology. On the basis of application, the market is segmented into Diagnostic and Treatment Monitoring. On the basis of end user, the market is segmented into Hospital Labs, Pathology Labs, Research Institutes and others.

Market numbers have been estimated based on average consumption and weighted average pricing of medical microbiology testing technologies and the revenue is derived through regional pricing trends and the epidemiology of specific diseases. Market size and forecast for each segment have been provided in the context of global and regional markets. The Medical Microbiology Testing Technologies market has been analyzed based on expected demand. All key end users have been considered and potential applications have been estimated on the basis of secondary sources and feedback from primary respondents. Regional demand patterns have been considered while estimating the market for various end users of Medical Microbiology Testing Technologies in different regions. Top down approach has been used to estimate the Medical Microbiology Testing Technologies market by regions. Market numbers for indication, technology, application, and end user segments have been derived using the top-down approach, which is cumulative of each region’s demand. Company-level market share has been derived on the basis of revenues reported by key manufacturers. The market has been forecast based on constant currency rates.

Global Medical Microbiology Testing Technologies Market: Competitive Landscape

A number of primary and secondary sources were consulted during the course of the study. Secondary sources include FACTIVA, NCBI, Google Books, company websites, journals, press releases, Morningstar, Hoover’s, and company annual reports and publications.

The report provides detailed competitive and company profiles of key participants operating in the global market. Key players in the global Medical Microbiology Testing Technologies market include Agilent Technologies Inc., Becton, Dickinson & Company, Beckman Coulter Inc. (A Danaher Company), Biomerieux SA, Bio-Rad Laboratories Inc., Roche Holding AG, among others.

The market has been segmented as below:

Global Medical Microbiology Testing Technologies Market – By Indication

Respiratory Diseases
Neurological Diseases
Infectious Diseases
Others

Global Medical Microbiology Testing Technologies Market – By Technology

Cell Culture
Microscopy
Serology

Global Medical Microbiology Testing Technologies Market – By Application

Diagnostic
Treatment Monitoring

Global Medical Microbiology Testing Technologies Market – By End User

Hospital Labs
Pathology Labs
Research Institutes
Others

Global Market Analysis of Human Papilloma Virus (HPV) Testing Forecasted to Expand with Strong CAGR of 16.17% through 2020

A new forecast study has been recently added to the online database of Market Research Hub (MRH), titled as “Global HPV Testing Market 2016-2020”. This study is examined by Technavio, who have studied the overall market to understand the market scenario and also to provide future growth prospects. By this study, analysts have forecasted the global market to grow at CAGR of 16.17% during the forecast period of 2016 to 2020. Initially, the report presents an overview on HPV and also highlights market landscape in the given forecast. Human Papilloma virus, commonly known as HPV is the term i.e. used for a group of more than 100 viruses that cause infection and do not have any symptoms. 

Health Care Industry

Nowadays, HPV infection is widespread. More than 40 types of HPVs causes highly contagious diseases which are transmitted through direct sexual contacts. Still, most HPV infections are harmless and heal by itself, apart from that high-risk types of genital HPV can be persistent and cause cervical, penile, vaginal, anal and oropharyngeal cancers. In the subsequent section, the research study segments the market by product, end-users, and geography. Geographically, key regions focused in the report are Americas, APAC and EMEA. Among these, Americas accounted for the maximum market share and will continue to maintain its dominance in the coming years.

Due to the growing number of cervical cancer patients in North America and also the government initiatives towards the awareness and adoption of HPV testing in countries like U.S., Canada and Brazil are growing, which is indeed boosting the market growth. Additionally, one the major challenges in the market is the presence of a limited number of health clinics and healthcare locations in developing countries. 

Further, segmentation by product includes: System and Consumables. On the other hand, end users of this market are- •Clinical diagnostic laboratories •Hospitals •Physician’s office laboratories Further, the report states that, several entities especially women, now undergo regular HPV tests as a precautionary measure. HPV tests help to identify the virus-related genetic material in a cell sample taken from the cervix, mostly used to detect cervical cancer in women. 

Additionally, the HPV Testing Market Report also discusses the cervical cancer diagnosis by HPV testing, which includes two types of screening tests. These tests are the most common way for doctors to distinguish and find pre-cancerous changes in cervical cancer. Currently, growing trend of early detection to prevent the growing prevalence of cervical cancer has been witnessed to drive the growth prospects for the global HPV testing market until the end of 2020. The report considers only HPV test products used for genital cancer screening to calculate the market size. Top vendors in the global market are- •Abbott Laboratories •Hologic •Roche Diagnostics •BD •Qiagen Some of the prominent vendors in the market are DAAN Gene, Genera Biosystems, OralDNA Labs, Trovagene, SoloPap, Arbor Vita etc. http://www.marketresearchhub.com/report/global-hpv-testing-market-2016-2020-report.html